Abstract
Technical advancements in molecular genetics have shown various mitochondrial DNA (mtDNA) abnormalities in patients with mitochondrial myopathies. Recently, it has been revealed that, in these patients, the nuclear DNA carries sequences similar to those of the mtDNA (nuclear pseudogene) and it has several point mutations previously reported to be pathogenic. We verified the existence of the T3250C and T3291C mutations, which we have found in patients with mitochondrial myopathy, in the authentic mitochondrial genome. A long polymerase chain reaction provides a powerful tool for avoiding nuclear pseudogene amplification and for ruling out ambiguity in the detection of the mutation for diagnosis.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Additional information
Received: August 2, 2000 / Accepted: August 30, 2000
Rights and permissions
About this article
Cite this article
Akanuma, J., Muraki, K., Komaki, H. et al. Two pathogenic point mutations exist in the authentic mitochondrial genome, not in the nuclear pseudogene. J Hum Genet 45, 337–341 (2000). https://doi.org/10.1007/s100380070004
Published:
Issue Date:
DOI: https://doi.org/10.1007/s100380070004
This article is cited by
-
Retinal dystrophy associated with a single-base deletion mutation in mitochondrial DNA 3271 in patient with MELAS syndrome
Documenta Ophthalmologica (2019)
-
Mitochondrial respiratory dysfunction disturbs neuronal and cardiac lineage commitment of human iPSCs
Cell Death & Disease (2017)
-
Molecular pathomechanisms and cell-type-specific disease phenotypes of MELAS caused by mutant mitochondrial tRNATrp
Acta Neuropathologica Communications (2015)
-
Homoplasmy of a mitochondrial 3697G>A mutation causes Leigh syndrome
Journal of Human Genetics (2014)
-
Mutations in mitochondrially encoded complex I enzyme as the second common cause in a cohort of Chinese patients with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes
Journal of Human Genetics (2011)